Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Health Assessment > Exam 4 - Heart Failure > Flashcards

Exam 4 - Heart Failure Flashcards

1
Q

Heart Failure is defined as a complex syndrome that results from:

A

any structural or functional impairment of ventricular filling or blood ejection

s2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Five signs of tissue-hypoperfusion that result from HF:

A

fatigue, dyspnea, weakness, edema, and weight gain

s2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HF may be caused by structural abnormalities of what 5 cardiac structures?

A

pericardium, myocardium, endocardium, heart valves, or great vessels

s2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what EF % classifies HF with reduced EF (aka systolic HF)?

A

EF ≤ 40%

s2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what EF % classifies HF with preserved EF (aka diastolic HF)?

A

EF ≥50%

s2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

A pt with clinical symptoms with an EF between ___ - ___% is labeled as having borderline HF w/ preserved EF

A

40-50%

s2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

True or false: Diastolic dysfunction is present in both HFrEF and HFpEF.

A

True!

s2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Patters of what 2 things are the major distinguishing features between HFrEF and HFpEF?

A

LV dilation and remodeling

s2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What serves as the main marker for establishment of HF risk factors, treatment, and outcome?

A

Ejection Fraction!

s2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which of the 2 HFs are women more likely to be affected by?

A

HF w preserved EF

s3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which of the 2 HFs are men more likely to be affected by?

A

HF with reduced EF

s3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which HF is more likely to have modifiable risk factors and a higher prevalence of MI, previous coronary intervention, CABG, and PVD?

A

HF w reduced EF

s3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the primary determinant of HFpEF?

A

left ventricular diastolic dysfunction

s4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what 5 things determine LV’s ability to fill?

A

pulmonary venous blood flow
LA function
mitral valve dynamics
pericardial restraint
active and passive elastic properties of LV

s4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What 3 things are majority of measurements of LV Diastolic dysfxn dependent on?

A

HR, loading conditions, and myocardial contractility

s4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Higher ________ are required to achieve normal end-diastole volume in pts with HFpEF.

A

LV filling pressures

s4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the steeper rise of the end-diastolic pressure-volume curve indicative of?

what does it result in regarding LV compliance?

A

delayed LV relaxation and an increase in myocardial stiffness

resulting in reduced LV compliance that restricts filling

s5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The reduced LV compliance that eventually restricts filling can precipitate what (regarding the left atrium and pulm system)?

A

LA hypertension, LA systolic & diastolic dysfunction,
pulmonary venous congestion, and exercise intolerance

s5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What does the left picture indicate about contractility?

what does the right picture indicate regarding LV compliance?

A

Left: a decrease in myocardial contractility as indicated by a decrease in the slope of the end-systolic pressure-volume relation

Right: a decrease in LV compliance as indicated by an increase in the position of the end-diastolic pressure-volume relation

These diagrams emphasize that heart failure may result from LV systolic or diastolic dysfunction independently

s5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

List some common causes of Left Ventricular Diastolic Dysfxn

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

LV End- diastolic dysfunction or delay in relaxation which is considered a form of “active stiffening” is complicated by

A

Failure of the actin-myosin disassociation, which occurs due to inadequate perfusion or dysfunctional intracellular Ca++ homeostasis

S9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

The NYHA system focuses primarily on ____ to classify HF?

A

the degree of physical limitation

S18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

The ACC/AHA focus on ____ to classify HF?

A

on the presence & severity of HF

S18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What should be noted with classification of HF?

A
  • note that these stages are progressive
  • oftenclassified using a combination of both scoring systems

S18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Which NYHA Classification has no limitation and no symptoms from ordinary activity?

A

NYHA Class I

S18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What NYHA Classification has mild limitation with activity and comfortable at rest or with mild exertion?

A

NYHA Class II

S18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Which NYHA Classification has significant limitation with any activity and comfortable only at rest?

A

NYHA Class III

S18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Which NYHA Classification has discomfort with any physical activity and symptoms occuring at rest?

A

NYHA Class IV

S18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Which ACC/AHA classification has high risk of developing heart failure but no functional or structural heart deficits?

A

ACC/AHA Class A

S18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Which ACC/AHA classification has structural heart deficit but no symptoms?

A

ACC/AHA Class B

S18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Which ACC/AHA classification has heart failure symptoms due to underlying structural heart deficit with medical management?

A

ACC/AHA Class C

S18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Which ACC/AHA classification has advanced disease requiring hospitalization, transplant, or palliative care?

A

ACC/AHA Class D

S18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Which condition has improved survival rate in the past three decades: HFrEF or HFpEF?

A

HFrEF

S19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Which condition benefits with using medications: HFrEF or HFpEF?

A

HFrEF

S19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What are the treatments for HFpEF?

A
  • Mitigation of sx’s
  • treat associated conditions
  • exercise
  • weight loss

S19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What are the treatments for HFrEF?

A
  • Beta Blockers
  • ACE-Inhibitors

S19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What class of medication stimulate β-receptors on the myocardium to activate adenylyl cyclase to increase cAMP?

A

Catecholamines

Slide 31

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

How does a implantable hemodynamic monitoring improve chronic HF?

A

it allows remote observation of intracardiac pressures to guide tx and prevent decompensation

Slide 24

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What are the medical treatments for Chronic HF?

A
  • Diuretics
  • B-blockers
  • ACE-inhibitors & ARBs
  • Lifestyle change

S21-22

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What are 2 important biomarkers in the diagnosis of HF?

A

BNP and N-terminal pro-BNP

17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

How does Loop Diuretics help CHF?

A
  • reduce LV filling pressures
  • decrease pulmonary venous congestion
  • improve HF sx

S21

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Which type of pts. are Thiazide diuretics useful and why?

A

pts with poorly controlled HTN
to prevent the onset of HFpEF

S21

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

How does a Implantable cardioverting-defibrillators (ICDs) helps patients with chronic Heat failure?

A

Its used to prevent sudden death in pts with advanced heart failure?

Slide 24

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Which type of CHF are Beta-Blockers strongly recommended for?

A

HFrEF
(HF with reduced EF)

prescribed for other indications (HTN, MI, HR control w/Afib)

S21

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

̴ ____% HF deaths are d/t sudden cardiac dysrhythmias

A

50%

Slide 24

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What is the mainstay treatment for HFrEF?

A

ACE-inhibitors and ARBs

(studies do not show benefit in HFpEF unless used for treatment of HTN)

S22

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What is the name of the device used by patients in the terminal stages of HF that may benefit from mechanical circulatory support (MCS) by a ventricular assist device (VAD)?

A

LV assist device

silde 25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What are the lifestyle changes that pt. can do to treat CHF?

A
  • Aerobic fitness
  • Weight loss
  • Salt-restricted, Dietary Approaches to Stop Hypertension (DASH) diet
  • Control of HTN and blood glucose

S22

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

HF preserved EF is associated w/ lower BNP and NT-proBNP levels [than HF reduced EF] due to what characteristics?

A

concentric hypertrophy, normal LV chamber size and lower LV end diastolic wall stress

17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Causes of LV relaxation

A

Due to afterload, which is elevated in hypertensive pts. Tachycardia exacerbates the failure of LV relaxation.

S9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

What is the goal of surgical treatment for CHF?

A

to prevent ventricular remodeling and retain the natural geometry of the heart

S23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

What are the benefits of coronary revascularization via CABG or PCI?

A
  • can reverse LV dysfunction following MI
  • may prevent permanent EF reductions
  • reduce 10-year mortality by 7% (CABG)

S23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

What is commonly seen w/ HFpEF despite having only a modestly depressed LV systolic fx?

A

Profound exercise intolerance

S9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

What is another name for Cardiac resynchronization therapy (CRT) and what is the treatment for?

A

“biventricular pacing”

tx for HF w/ ventricular conduction delay (prolonged QRS)

S23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Cardiac resynchronization therapy (CRT)

Placement of a ____ cardiac pacemaker (w/RA & RV leads), an additional lead is introduced through the coronary sinus and advanced until it reaches the lateral wall of the ____.

This stimulates the heart to contract more ____ and efficiently and improve COP

A

dual chamber

LV

synchronously

S23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Prolonged compression of coronary arteries restricts diastolic coronary blood flow, which contributes to ____ ____ and a further reduction in exercise tolerance.

A

subendocardial ischemia

S9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

What NYHA class is CRT recommended?

A

NYHA class III or IV w/ EF < 5% and a QRS duration 120-150 ms

S23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

What are the outcomes of CRT?

A
  • fewer HF sx
  • better exercise tolerance
  • improved ventricular function
  • less hospitalizations
  • decreased mortality

S23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

What are the most common symptoms of HF?

A

Fatigue, tachypnea, dyspnea, paroxysmal nocturnal dyspnea, orthopnea, S3 gallop, JVD, peripheral edema, exercise intolerance, and reduced tissue perfusion.

S10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

What are the risks of CRT?

A
  • infection
  • misplacement
  • device failure

S23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

What are the most common symptoms of HFpEF?

A

paroxysmal nocturnal dyspnea, pulmonary edema, dependent edema

s10

63
Q

What is the most common sign of HFrEF?

A

S3 gallop

S10

64
Q

CRP and GDF15 (growth differentation factor 15 represent what component of HF?

A

inflammatory component of HF

17

65
Q

When EF is reduced, the presence of HF symptoms establishes the diagnosis of?

A

HFrEF (following standard guidelines)

S10

66
Q

LVAD is used for

A
  • temporary ventricular assistance while heart is recovering its function
  • Pts awaiting cardiac transplant
  • Pts are on inotropes or balloon pump (IABP) with potentially reversible medical conditions
  • Pts with advanced HF who aren’t transplant candidates

Slide 25

67
Q

Which type of HR is harder to diagnose?

A

HFpEFis often more difficult to diagnose,especially when the pt has little/no symptoms at rest

S11

68
Q

What is disease process is classified as a long-standing HF disease?

A

Chronic heart failure

Slide 27

69
Q

What does cardiac catheterization define?

A

Elevated LV systolic and diastolic stiffness usingpressure-volume analysis or provocative testing (s/a exercise & rapid IV volumeexpansion)

S11

70
Q

What other diagnostic measure can offer further information about severity of HFpEF?

A

Direct measurement of RV filling.

S11

71
Q

True or false: Acute heart failure: Slow onset, often presenting w/life-threatening conditions

A

False: Acute heart failure: rapid onset, often presenting w/life-threatening conditions

Pts may require hospitalization, txis aimed at decreasing volume & stabilizing hemodynamics

Slide 27

72
Q

What diagnostic finding provides strong evidence of HFpEF and is a predictor of mortality?

A

Mean pulmonary capillary wedge pressure >15mmHg at rest or 25mmHg duringexercise

S11

73
Q

The term Acute heart failure applies to what patient population?

A
  • present with worsening preexisting HF
  • present for the first time with HF

Slide 27

74
Q

What would you expect to see on CXR of someone w/ HF?

A

pulmonary dz, cardiomegaly, pulmonary venous congestion, and interstitial or alveolar pulmonary edema.

S13

75
Q

What is an early radiographic sign of LV failure and pulmonary venous HTN?

A

distention of the pulmonary veins in the upper lobes of the lungs

S13

76
Q

What are the sx of ADHF?

A
  • **fluid retention
  • weight gain
  • dyspnea**
    as the result of decompensation due to inadequate compensation

Slide 27

77
Q

You read in the chart that the pt has perivascular edema, so you look at pt’s CXR and you see…

A

hilar or perihilar haze with ill-defined margins

S13

78
Q

What are the characteristics of De novo AHF?

A
  • increase in intracardiac filling
  • pressuresor acute myocardial dysfunction
  • decreased peripheral perfusion
  • pulmonary edema

Slide 28

79
Q

Pt presents with interlobular edema. What would you expect to see on CXR?

A

Kerley lines, which produce a honeycomb pattern

S13

80
Q

What is the leading caused of de novo HF?

A
  • Cardiac ischemia cause by a coronary occlusion
81
Q

How can a SRNA stabilize a patient with cardiac ischemia caused by a coronary occlusion ?

A
  • stabilizing hemodynamics
  • restoring myocardial perfusion
  • improving myocardial contractility

Slide 28

82
Q

Pt presents with alveolar edema, what would you expect to see on CXR?

A

homogeneous densities in the lung fields, typically in a butterfly pattern

S13

83
Q

Radiographic evidence of pulmonary edema may lag behind the clinical evidence of pulmonary edema by up to ____hours

A

12 hours

S13

84
Q

Myocardial hypertrophy, dynamic LV outflow obstruction, mitral regurg, diastolic dysfunction, myocardial ischemia and dysrhythmias are all related to what condition?

A

hypertrophic cardiomyopathy

45

85
Q

Nonischemic cause of de novo HF include

A
  • drug-induced (toxic)
  • peripartum cardiomyopathies

Slide 28

86
Q

Hypertrophied myocardium has a ____ relaxation time and ___ compliance

A

prolonged relaxation and decreased compliance!

45

87
Q

Which criteria is more specific in diagnosis of HFpEF and incorporates several echocardiographic indexes based on 2-dimensional measurements?

A

European Sociaty of Cardiology (ESC)

S15

88
Q

De novo HF may lead to _____ _________ dysfunction.

A

long-term cardiac dysfunction

management of theunderlying causemay allow for complete restoration

Slide 28

88
Q

Nesiritide works by inhibiting the ________ and promoting arterial, venous, and coronary vaso-____________, decreasing LVEDP and improving ___________.

A

Nesiritide works by inhibiting the **RAAS **and promotingarterial, venous, and coronary vasodilation, decreasing LVEDP and improving dyspnea

33 - AHF

89
Q

ESC guidelines rely entirely on ____ echocardiogram; and are limited because they do not incorporate ____testing.

A

resting
provocative

S15

89
Q

Nesiritide induces diuresis and ____________, relaxes cardiac muscle, and lacks any ____________ effects

A

Nesiritide induces diuresis and natriuresis, relaxes cardiac muscle, and lacks any dysrhythmic effects

Natriuresis is when the body excretes more sodium and causes a diuretic response

33 - AHF

90
Q

European Society of Cardiology criterias

A

S15

90
Q

What class of medication is proven to correct elevated filling pressures and reduceafterload.

A

Vasodilators

Slide 30

90
Q

T/F
Nesiritide has shown advantage over traditional vasodilators such as NTG & SNP

A

False
Nesiritide has not shown advantage over traditional vasodilators such as NTG & SNP

33 - AHF

91
Q

The hemodynamic profile that is included in acute HF?

A
  • low cardiac output
  • high ventricular filling pressures
  • HTN or HoTN

Slide 29

91
Q

hypertrophic cardiomyopathy

Surgery is reserved for pt w/ large outflow tract gradients & severe symtoms despite medical tx. What are 3 surgical strategies?

What treatment if still symptomatic?

A

-septal myomectomy
-cardiac cath w/ injection to induce ischemia to septal perforator arteries
-echo guided percutaneous septal ablation

If still symptomatic, MVR can be done to counteract systolic anterior motion of mitral leaflet

48

92
Q

What underlying pathologies are common in HF pts with EKG abnormalities?

A

LVH, previous MI, arrhythmias and conduction abnormalities

S16

92
Q

Which medication is effective in rapidly decreasing afterload?

Which medicatioin is used as an adjunct to diurectic therapy?

A
  • SNP
  • NTG

Slide 30

93
Q

T or F?

Myocardial ischemia is present in Hypertrophic cardiomyoapthy whether or not they have CAD

A

True

45

93
Q

hypertrophic cardiomyopathy

What is the primary tx for pt at risk for death r/t dysrhytmias?

A

ICD placement!

48

94
Q

Dysthytmias are the most sudden cause of death in young pts w/ hypertrophic cardiomyopathy. What causes dysrthymias?

A

disorganized cellular architecture, scarring, and an expanded interstitial matrix

45

95
Q

What are the 6 most common inotropic drugs used in AHF? (chart)

A

32 - AHF

95
Q

What characterizes dilated cardiomyoapthy
what is the initial symptom?

A

LV [or biventricular] dilation, biatrial dilation, decreased ventricular wall thickness, and systolic dysfunction

initial symptom–> HF (CP may occur as well)

46

96
Q

What is the first line of treatment for AHF should be given immediately in pts with fluid overload to mitigate?

A

Diuretics

Slide 29

96
Q

What is class of medication emerged as potential adjunct therapy, to reduce the arterial constriction, hyponatremia, and the volume overload associated with AHF?

A

Vasopressin receptor antagonists

Slide 30

97
Q

In asymptomatic patients, what is the only sign of Hypertrophic cardiomyopathy?

A

unexplained left ventricular hypertrophy

46

98
Q

What Exogenous recombinant BNP binds to A and B-type natriuretic receptors?

A

Exogenous BNP: Nesiritide, a recombinant BNP that binds to A- and B-type natriuretic receptors

33 - AHF

99
Q

What are some diagnostic abnormalities in patients w/ hypertrophic cardiomyopathy?
hint: ekg and echo

A

EKG abnormalities (75-90% pt) show high QRS voltage, ST segment and T wave abnormalities, abnormal Q, and atrial enlargment
Echo: myocardial wall thickness >15mm; and EF >80%
terminal states: EF severely depressed

46

99
Q

What is an example of Vasopressin receptor antagonists?

A

Tolvapatan

Slide 30

100
Q

True of false: An AHF patient with hypotension or cardiogenic shock may first require hemodynamic support prior to diuretic therapy.

A

True

29

100
Q

dilated cardiomyoapthy

Ventricular dilation may lead to what 2 valve abnormalities?

A

mitral and tricuspic regurgitation

49

101
Q

Which diagnostic testing has low predictive value for diagnosis or risk- prediction of heart failure?

A

EKG alone

S16

102
Q

What are the diruetic given as a bolus followup by a continous infusion

A

Furosemide
Bumetanide
Torsemide

given as bolus or continuous infusions

Slide 29

102
Q
A
103
Q

hypertrophic cardiomyopathy

Cardiac catherization allows direct measurement of ______ ____?

A

left ventricular end diastolic pressure

46

103
Q

Common complications in dilated cardiomyopathy? (4)

A

dysrhythmias, conduction abnormalities, emboli and sudden death

49

104
Q

Medical treatment for hypertrophic cardiomyopathy (4)

A

-BB, CCB
-if develop HF–> diuretics
-disopyramide (add on if still symptomatic)
-amiodarone if develops dysrhythmias! (most effective)

disopyramide has negative inotropic effect- improves LV outflow obsructi

47

104
Q

When medical management fails and organ dysfunction occurs, urgent _________ ___________ __________ (MCS) is indicated.

A

When medical management fails and organ dysfunction occurs, urgent mechanical circulatory support (MCS) is indicated

34 - AHF

105
Q

Reducing in_________ _________ leads to decreased________ ________ and ________ _______ _________ __________ (______), reducing pulmonary congestion.

A

intravascular volume
central venous
pulmonary capillary wedge pressures (PCWP)

Slide 29

105
Q

Common echo and EKF findings in dilated cardiomyopathy are?

A
  • echo: dilation of all 4 chambers, especially the LV. Global hypokinesis
  • EKG: ST and T wave abnormalities w/ LBBB
  • comon dyrhythmias: PVC and AFIB

50

106
Q

What complication that develops in hypertrophic cardiomyopathy is associated w/ increased risk of thromboembolism, HF and death?

What is the treatment

A

a-fib–> amiodarone!
Need long term anticoagulation if chronic

47

106
Q

The Society of Thoracic Surgeons (STS) developed a MCS decision-making tool based on pt clinical profiles. What is that tool or Profile System called?

A

Inter-agency Registry of Mechanically Assisted Circulatory Support
INTERMACS Profile System

34 - AHF

107
Q

Treatment for dilated cardiomyopathy

A

Tx is similiar to chronic HF. AC initiated as well.
Prophylactic ICD–> decreases sudden death by 50%

Ultimately–> cardiac transplant :( (DCM is the main indication for transplant)

50

108
Q

What are some examples of catecholamines being use for Acute HF treatment?

A

epinephrine
norepinephrine
dopamine
dobutamine

Slide 31

109
Q

What is a class of medication indirectly increase cAMP by inhibiting its degradation to help treat acute HF?

What is an example of this medication ?

A

PDE-inhibitors
milrinone

Slide 31

110
Q

Stress cardiomyopathy aka apical ballooning syndrome is a temporary primary cardiomyopathy characterized by what abnormalities?

A

LV apical hypokinesis and ischemic EKG changes (coronary arteries are still patent)

-Temporary dysruption of contractility in LV apex (and rest of heart has normal contractility)

51

111
Q

___________ _______________ Pump: functions by cyclic ____________balloon inflation after ________ valve closure, followed by deflation during __________

A

Intraaortic Balloon Pump (IABP): functions by cyclic helium balloon inflation after aortic valve closure, followed by deflation during systole

35 - AHF

113
Q

Common symptoms in stress cardiomyopathy? What is the most common cause?

A

chest pain, dyspnea.
Stress is most common cause
women > men

51

114
Q
A
115
Q

IABP improves LV coronary perfusion by ____________ LVEDP

____________and x-ray are the primary modes for placement evaluation

A

IABP improve LV coronary perfusion by **reducing **LVEDP

TEE and x-ray are the primary modes for placement evaluation

35 - AHF

116
Q

IABP degree of support varies because of the set ____________, the ________ of the balloon, and the ____________ of supported beats

A

IABP degree of support varies b/o the set volume, the size of the balloon, and the ratio of supported beats

35 - AHF

117
Q

Full IABP support would be 1:1 (one inflation for every heartbeat)

In tachycardic pts, a setting of __:__

(________ inflation per every________ heartbeats) is ideal

A

Full support would be 1:1 (one inflation for every heartbeat)

In tachycardic pts, a setting of 1:2 (one inflation per every two heartbeats) is ideal

35 - AHF

118
Q

IABP provides only ____________ improvements in cardiac output
(_____-_____ L/min) and render pts immobile, limiting its long-term use

A

Overall, IABP provides only modest improvements in cardiac output (0.5–1 L/min) and render pts immobile, limiting its long-term use

35 - AHF

119
Q

What is a Ventricular Assist Device (VAD) that can be placed percutaneously to reduce LV strain and myocardial work in the setting of acute heart failure?

A

Impella

36 - AHF

120
Q

How long can an Impella be left in a patient for?

A

Can be utilized for up to 14 days

36 - AHF

121
Q

An Impella serves a transition to ____________ or a bridge to ____________ procedures.

What are the four procedures mentioned on this slide?

A

Serves as a transition torecovery

Bridge to cardiac procedures (CABG, PCI, VAD, transplant)

36 - AHF

122
Q

The Impella consists of a miniature ____________ blood pump inserted through the ____________ artery, advanced through the aortic valve and is situated in the ______

A

The Impella consists of a miniature rotary blood pump inserted through the **femoral **artery, advanced through the aortic valve and is situated in the LV

36 - AHF

123
Q

The Impella pump draws blood continuously from the LV through the ________port and ejects it into the ascending aorta through its ____________ port

A

The Impella pump draws blood continuously from the LV through the distal port and ejects it into the ascending aorta through its proximal port

36- AHF

124
Q

____________ VAD: support devices that can provide extracorporeal membrane oxygenation (ECMO)

Consists of a small pump & controller, which is helpful for transport, but generates ________, causing more ________ and lower flows.

A

Peripheral VAD: support devices that can provide extracorporeal membrane oxygenation (ECMO)

Consists of a small pump & controller, which is helpful for transport, but generates heat, causing more hemolysis and lower flows

38 - AHF

125
Q

Peripheral VAD: If these devices have an ____________, they are considered ECMO, and used to support the right or left side of the heart

A

If these devices have an oxygenator, they are considered ECMO, as opposed to having no oxygenator, but used to support the right or left side of the heart

38 - AHF

126
Q

What VAD/ECMO device is necessary for cardiorespiratory support or as an alternative to Peripheral VAD/ECMO?

Why would we use this device over Peripheral VAD/ECMO?

A

Central ECMO may be necessary for cardiorespiratory support or as an alternative to peripheral ECMO

We would use Central ECMO if adequate flow rates are not achievable with Peripheral VAD.

36 - AHF

127
Q

Where are Central VAD/ECMO devices placed (2 spots)?

How are these spots surgically accessed?

A

Central cannulas are placed in the right atrium and aorta
Accessed:
Invasive and require sternotomy or thoracotomy for placement

36 - AHF

128
Q

What are the three benefits of Central VAD/ECMO?

A

Benefits:
1. complete ventricular decompression
2. avoidance of limb impairment
3. avoidance of SVC syndrome

36 - AHF

129
Q

T/F
Pts on ECMO likely have increased lung perfusion as blood bypasses the lungs before returning to the aorta

A

FALSE
Pts on ECMO likely have reduced lung perfusion as blood bypasses the lungs before returning to the aorta

39 - AHF

130
Q

Due to ECMO ____________anesthetics may be significantly limited by functional shunting around the lungs

For this reason what other anesthetic techniques are considered?

A

**Inhaled anesthetics **may be significantly limited by functional shunting around the lungs
higher amount of inhaled anesthetics may be required

TIVA should be considered for pts on ECMO

39 - AHF

131
Q

The CRNA should recognize that the ECMO membrane is ____________, causing many agents, including fentanyl, to become ____________within the circuit.

A

CRNA must recognize that the ECMO membrane is lipophilic, causing many agents, including fentanyl, to become sequesteredwithin the circuit

39 - AHF

132
Q
  • Peripheral VAD = __________ membrane oxygenation (ECMO)
  • Consists of a small pump & controller = helpful for _______,
  • but generates ____&raquo_space; ______ and lower flows
  • If oxygenator = ECMO,
  • no oxygenator = used to ______ R or L heart

AHF Surgical Treatment

A
  • extracorpeal
  • transport
  • heat … hemolysis
  • support
133
Q

Cetnral VAD/ECMO

  • cannulas placed in ___ atrium + aorta
  • invasive _____ / ______ to place
  • benefits = complete _____ decompresion ,, avoid ____ impairment ,, avoid ____ syndrome

AHF Surgical Treatment

A
  • Right
  • sternotomy / thoracotomy
  • ventriuclar ,, limb ,, SVC
134
Q

ECMO

  • Pts on ECMO have reduced ____ perfusion bc blood bypasses before returning to aorta
  • Inhaled Anes = ____ bc of shunting
  • _____ should be considered for ECMO pts
  • ECMO membrane = ____ + may cause agents like ____ to become sequestered within circuit

AHF Surgical Tx

A
  • lung
  • limited
  • TIVA
  • lipophilic ,, fentanyl
135
Q

Biventricular Assist Device

  • Used to _____ support of ventricles with 2 independent circuits
  • This allows for ______ of either L or R sided support
  • separate circuits achieved by _____ placement
  • R + L sides can be centrally ______ individually

AHF Surgical Tx

A
  • decouple
  • weaning
  • percutaneous
  • cannulated
136
Q
  • HF pts have increased risk of :: ___ failure, ______, pna, + require longer periods of ______ _________
  • Comprehensive preop exam to determine if ______ or require treatment
  • 3 reasons to POSTPONE surgery ??

AHF Preoperative Mgmt

A
  • Renal failure ,, sepsis ,, mechanical ventilation
  • compensated
  • decompensation ,, change in status ,, De Novo AHF
137
Q
  • ____ held on day of surgery
  • continue ____ bc it’s managment is essential
  • ______ put pt at risk for intraop Hotn
  • perform a _______ if worsening dyspnea
  • 4 labs necessary ??
  • ____ lab is not routine
  • ICDs and Pacemakers should be ______ prior to surgery

AHF Preoperative Mgmt

A
  • Diuretics
  • Beta blockers
  • ACE-I
  • TTE – echo
  • CBC , lytes , LFTs , coagulation
  • BNP
  • interrogated
138
Q
  • Group of myocardial disease with ___________ or _____ dysfx
  • These exhibit as ventricular __________ or ________
  • Cardiomyopathy is either confined to __________ (primary) or part of _____ disorders (secondary)

Cardiomyopathies

A
  • mechanical or electrical
  • hypertrophy or dilation
  • heart or systemic
139
Q
  • affects all ___
  • most common ______ CV disease
  • characterized by _____ + absence of other diseases that could cause it
  • presents with hypertrophy of the ___________________ and ________________
  • Histologic features are hypertrophied ____ cells and ________ myocardial scarring

Hypertrophic Cardiomyopathy

A
  • ages
  • genetic
  • L Ventricle Hypertrophy
  • intraventricular septum and antero-lateral free wall
  • myocardial ,, patchy

Health Assessment (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions